Drug Profile
Research programme: calcium antagonists - Eisai
Latest Information Update: 07 Dec 2006
Price :
$50
*
At a glance
- Originator Eisai Co Ltd
- Class
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 19 Apr 2001 Preclinical development for Stroke in Japan (Unknown route)